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Abstract
Background: In the Atlantic forest of the North and Northeast regions of Brazil, local population often uses the fruit
juice and the aqueous extract of leaves of soursop (Annona muricata L.) to treat Lachesis muta rhombeata
envenomation. Envenomation is a relevant health issue in these areas, especially due to its severity and because the
production and distribution of antivenom is limited in these regions. The aim of the present study was to evaluate
the relevance of the use of soursop leaf extract and its juice against envenomation by Lachesis muta rhombeata.
Methods: We evaluated the biochemical, hematological and hemostatic parameters, the blood pressure, the
inflammation process and the lethality induced by Lachesis muta rhombeata snake venom. We also assessed the
action of the aqueous extract of leaves (AmL) and juice (AmJ) from A. muricata on the animal organism injected
with L. m. rhombeata venom (LmrV) in the laboratory environment.
Results: LmrV induced a decrease of total protein, albumin and glucose; and increase of creatine kinase, aspartate
aminotransferase, and urea concentrations. It provoked hemoconcentration followed by reduction of hematocrit, an
increase in prothrombin time and partial thromboplastin time and a decrease of the blood pressure. LmrV induced
the release of interleukin-6, an increase in neutrophils and changes in the serum protein profile, characteristic of the
acute inflammatory process. LD50 values were similar for the groups injected with LmrV and treated or untreated
with AmJ and AmL. Both treatments play a role on the maintenance of blood glucose, urea and coagulation
parameters and exert a protective action against the myotoxicity. However, they seem to worsen the hypotension
caused by LmrV.
Conclusion: The treatments with AmJ and AmL present some beneficial actions, but they might intensify some
effects of the venom. Therefore, additional studies on A. muricata are necessary to enable its use as natural
antivenom for bushmaster snakebite.
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Background
The species L. muta is divided into two subspecies: L.
muta muta found in tropical forests of Colombia,
Venezuela, Guyana, Suriname, Peru, Ecuador and Brazil,
and L. muta rhombeata confined to certain areas of the
rainforest of the Brazilian Atlantic region [1, 2]. Lachesis
muta rhombeata was considered “endangered of extinc-
tion” in 1989 by the official list of the Brazilian Institute of
Environment and Renewable Natural Resources (IBAMA),
and currently is considered “vulnerable” by the Inter-
national Union for the Conservation of Nature [3].
The envenomation caused by Lachesis genus repre-
sents 4.5 % of all registered snakebites in Brazil and is
characterized by the so-called “Lachesis Syndrome” [4].
Within the first few minutes after the bite, the victim is
affected by agonizing burning throbbing local pain and
edema, followed by intense inflammation, bleeding dis-
orders, clotting disorders, kidney malfunction, myotoxicity
and autonomic syndrome evidenced by sweating, nausea,
vomiting, abdominal cramps, diarrhea, hypotension and
bradycardia [5–9].
The venom is rich in proteolytic enzymes responsible
for severe local effects such as swelling, local inflammation
and necrosis mainly due to the action of phospholipases
A2 (PLA2) and metalloproteinases [7]. Hemorrhagic ef-
fects are attributed to alpha-fibrinogenases, active on the
factor XIII of the coagulation cascade, and hemorrhagic
metalloproteinases that provoke microvascular damage in
the organism, which leads to internal bleeding [10–16].
This effect is enhanced by the action of thrombin-like
serine proteinases and C-type lectins that respectively in-
duce the consumption of fibrinogen and cause platelet ag-
gregation and hemaglutination [7, 17–24]. Together, they
provoke the disturbance in blood coagulation and collab-
orate with the hemorrhagic profile observed during the
envenomation.
The PLA2 exerts indirect hemolytic effect and plays a
major role in neurotoxic symptoms (stimulation of the
autonomic nervous system) and causes vomiting, diarrhea,
sweating, hyper salivation, bradycardia and hypotension in
human victims [7, 23, 25–31]. Other components of the
venom include L-amino acid oxidases, bradykinin potenti-
ating peptides, cysteine-rich secretory proteins, C-type
natriuretic peptides, nerve growth factors and hyaluroni-
dases [7, 24, 32–36].
Up to the present, the only specific therapy available
for snake envenomation is the serotherapy. Its efficiency
is mainly related to the amount of venom injected and
the time elapsed between the accident and the start of
treatment [37]. Despite being the treatment of choice, it
is limited to regions that have structured health centers
and may provoke several side effects, which makes the
search for additional and/or alternative treatments even
more important [6, 34]. Moreover, the venom of L. muta
has low immunogenic capacity, when compared with
other venoms [38].
Plants popularly used to maintain or restore human
health provide an important source of compounds able to
directly assist in the treatment of accidents with venom-
ous animals, or indirectly, as a complement to conven-
tional antivenom therapy. The use of plant extracts, as an
antidote against venoms is an old option for many com-
munities that need rapid access to antivenom therapy.
In the Atlantic forest of the North and Northeast re-
gions of Brazil, the fruit juice and the aqueous extract of
soursop (Annona muricata L.) leaves are often used by
local population to treat Lachesis muta rhombeata en-
venomation [39]. The envenomation caused by Lachesis
genus comprises an important health issue, especially in
regions where the production and distribution of anti-
venom are limited. The search for alternative methods
to minimize or delay the action of the venom is a neces-
sity and should be encouraged.
The aim of the current study was to evaluate the rele-
vance of the use of leaf extracts and juice of Annona muri-
cata L., a plant traditionally used in the Brazilian Northeast
region against Lachesis muta rhombeata venom.
Methods
Venom
The venom was kindly provided by Rodrigo C. Gonçalves
de Souza, founder and director of the Núcleo Serra
Grande for Captive Breeding of Lachesis muta rhombeata,
Federal Technical Registry No. 495100. The present study
was approved by IBAMA (process no. 14785–1).
Annona muricata L.
The aqueous extract of Annona muricata L. leaves
(AmL) was prepared by maceration of 20 g of fresh
leaves newly collected in the presence of 80 mL of water
and then the extract was filtered through a clean cotton
fabric. Annona muricata L. juice (AmJ) was prepared in
proportion of 50 % pulp and 50 % drinking water. The
leaf extract and juice were administered by gavage to an-
imals. For this study, three preparations of 0.5 mL
(water, AmJ or AmL) were administered by gavage, 1 h
and 15 min before and 1 h after intramuscular (i.m.) in-
jection of saline (control, 200 μL) or venom (200 μL, 3
mg/rat). The voucher specimen is deposited at the
Herbarium of University of São Paulo – SPFR, in the
city of Ribeirão Preto, SP, Brazil, under the collector
identification MGroppo 1886.
Experimental groups
Animal care was in accordance with ethical recommen-
dations of the International Guiding Principles for Bio-
medical Research Involving Animals and the study was
approved by the Ethics Commission for the Use of
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Animals (CEUA) of the University of São Paulo, Campus
of Ribeirão Preto (process no 07.1.277.53.1). Male Wistar
rats (209 ± 12 g) were supplied by the Central Biotherium
(University of São Paulo, Campus of Ribeirão Preto).
The animals were divided into six groups that were
analyzed in different times. Each animal from the groups
LmrV, LmrV + AmL and LmrV + AmJ received an intra-
muscular injection of 3 mg of venom diluted in physio-
logical solution (200 μL), which is a previously
determined non-lethal dose (data not shown) and re-
ceived, respectively, water, aqueous extract of soursop
leaves and soursop juice. The control groups C, C +
AmL and C + AmJ received an intramuscular injection
of physiological solution (200 μL) followed by water,
aqueous extract of soursop leaves and soursop juice, re-
spectively. Each group was evaluated in three different
times after injection of physiological solution or venom:
1, 6 and 24 h.
At the appointed time for each subgroup (1, 6 or 24 h
after injection), the animals were anesthetized with a intra-
peritoneal injection of a mixture of ketamine (35 mg/kg)
and xylazine (5 mg/kg), and subjected to cardiac puncture
for collecting blood. Then, they were euthanized in a CO2
chamber.
Biochemical parameters
The concentrations of albumin, total protein, blood glu-
cose, urea, creatinin, aspartate aminotranspherase (AST)
and creatine kinase (CK) were evaluated in the serum of
the animals submitted to different treatments. All bio-
chemical analyses were performed at the Laboratory of
Clinical Analysis of the School of Pharmaceutical Sciences
of Ribeirão Preto in an automated analyzer BT 3000 Plus
(Wiener Lab, Argentina, serial number 41080340).
Hematological parameters
Hematological parameters were determined in whole
blood of animals using classical methods: volume of
packed red blood cells or hematocrit (Ht) by the micro-
hematocrit method, total hemoglobin concentration
(Hb) by the cyanmethemoglobin method, red blood cells
(RBC) count with a Neubauer hemacytometer using
Hayem diluting fluid.
Hemostatic parameters
The prothrombin time and partial thromboplastin time
were determined using a commercial kit of Wiener Lab
(Wiener Lab, Argentina).
Blood pressure
The blood pressure was evaluated by tail-cuff plethys-
mography with heating [40, 41].
Inflammatory process
The assays used to evaluate the inflammatory profile
triggered by Lachesis muta rhombeata envenomation
were the global leukocyte count, differential leukocyte
count, serum protein quantification after electrophoresis
in agarose gel and concentration of interleukin-6, deter-
mined by enzyme immunoassay (commercial kit from R
& D Systems). Serum proteins were separated by agarose
electrophoresis [42]. Bands were quantified by densitom-
etry (DenGo Densitometer, Qualiterm, Brazil).
Lethality assay
The lethal dose 50 (LD50) for Lachesis muta rhombeata
venom was calculated by the probits method [43]. Three
experimental groups (see below) of male Balb-C mice
(22 ± 3 g) were injected with four different doses of
venom (100 μL, i.m.): 10, 20, 40 and 80 mg/kg (ten ani-
mals per dose). The choice of the venom doses was
based on the studies of Otero et al. [25].
1. LmrV: animals received water (150 mL) by gavage
15 min before venom injection.
2. LmrV + AmL: animals were administered aqueous
extract of soursop leaves (150 mL) by gavage 15 min
before venom injection.
3. LmrV + AmJ: animals received soursop juice (150
mL) by gavage 15 min before venom injection.
Statistical analysis
The results are expressed as mean ± standard error of
mean (SEM). The statistical analysis was carried out by
one-way ANOVA followed by Tukey-Kramer post-hoc test
with a significance level set at p < 0.05, using Graphpad
Prism® 4.0 software for Windows™.
Results and discussion
Biochemical parameters
A time-dependent decrease is observed for total protein
and albumin (Fig. 1 – a and b) in groups in which ani-
mals were injected with venom, which is consistent with
the intensity of the inflammatory process triggered by
the envenomation. The biochemical changes observed in
L. muta rhombeata envenomation are consequences of
the main action of enzymes present in the venom, such
as PLA2, thrombin like serine proteinases and metallo-
proteinases. PLA2 and metalloproteinases exert intense
inflammatory and myotoxic effects. The inflammatory
process triggers an acute phase reaction, altering the
concentration of serum proteins, mainly albumin, which
is part of the group of negative acute phase inflamma-
tory proteins, and its synthesis is reduced during the
inflammatory process. The decrease of total protein con-
centration occurs along with the reduction of albumin
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concentration, since this is the most abundant protein in
blood [44].
The results show an increase of serum urea (Fig. 1 – c)
during the early hours after the venom injection in the un-
treated group (LmrV 1 h and LmrV 6 h) and in treated
groups (LmrV +AmL, 1 h and 6 h; LmrV +AmJ, 1 h and 6
h), but increases in serum urea observed in the treated
groups were lower (6 h) than those observed in untreated
animals, showing that treatment may be able to partially re-
verse this effect of the venom. After 24 h of envenomation,
the concentration of urea tend to return to control values.
The increased concentrations of urea and creatinine
are commonly observed after Lachesis muta envenom-
ation in humans [6, 45]. The fibrin clots may be respon-
sible for this response observed in the groups injected
with venom. According to Souza [45] and Lima et al.
[23], the increase of urea is possibly the result of depos-
ition of fibrin clots in the kidneys due to the action of
thrombin-like serine proteinases present in Lachesis
venom, which promotes thrombin cleavage into fibrino-
gen and fibrin clots. The venom-induced renal damage
could also be a consequence of the myoglobin deposit in
the kidney, since the venom is myotoxic, or due to pe-
riods of renal hypotension [29, 46].
The increase in creatinine concentration is usually ac-
companied by increased concentrations of urea, as indica-
tive of decreased glomerular filtration rate. Pardal et al. [8]
in a case report, noted an increase in creatinine during the
first day after the snakebite, which returned to normal
levels of concentration after that. Although the animals
had shown increased urea levels in the early hours (1 and
6 h) after the envenomation, no changes were observed in
serum creatinine (data not shown).
A time-dependent decrease was also observed in blood
glucose (Fig. 1 – d) in the group injected with LmrV as
well as the maintenance of normal glucose values in the
group treated with aqueous extract of Annona muricata
L. leaves (LmrV + AmL), evidencing that AmL treatment
was able to control glucose levels. Taylor [47] de-
scribes the popular use of soursop to control the
blood glucose levels of diabetic people, in Amazonian
region of Peru.
Fig. 1 a Concentration of total proteins, b albumin, c urea, d glucose, e CK and f AST in the serum of male Wistar rats injected with 3 mg of Lachesis
muta rhombeata venom, at 1, 6 and 24 h after envenomation (LmrV) and with their respective treatments with aqueous extract of Annona muricata L.
leaves (LmrV + AmL) or Annona muricata L. juice (LmrV + AmJ). The numbers above the columns represent the number of animals used in each test.
*** p < 0.001, ** p < 0.01, * p 0.05 compared to control group. p < 0.05, °° p < 0.01 compared with the envenomation group (LmrV)
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The Fig. 1 – E shows that LmrV induces an increase
of CK, which is a biomarker of muscle damage, in the
1st and 6th hours, while Fig. 1 – F shows an increase in
AST mainly 24 h after envenomation. These effects are
probably due to the myotoxic action of venom PLA2, as
well as the action of metalloproteinases that indirectly
lead to death of muscle fibers, due to the reduction
of tissue perfusion [23, 26, 29,]. CK levels in groups
LmrV + AmL and LmrV + AmJ, both 6 h after en-
venomation, are lower than that observed in the un-
treated group LmrV (Fig. 1 – e), suggesting a
protective effect of the juice and aqueous extract of
soursop leaves against myotoxic activity of the venom.
Although not significant, there is a reduction of CK
concentration 24 h after envenomation in the treated
groups when compared to the untreated group (LmrV
24 h), which reinforces the hypothesis that the treat-
ment may have protective effect against the myotoxi-
city of Lachesis muta rhombeata venom.
There was an increase in AST (Fig. 1 – f ) observed in
groups LmrV, LmrV + AmL and LmrV + AmJ, mainly 24
h after injection of the venom. AST is a sensitive marker
for liver damage, but its significant increase in groups
injected with LmrV does not necessarily indicates liver
damage, since AST is also distributed in appreciable
amounts in cardiac tissues, muscles, red blood cells,
brain and kidney, and this increase may be due to
hemolysis and/or myotoxicity caused by the envenom-
ation [48]. In case reports published by Jorge et al. [7] and
Torres et al. [49], both also described increased liver trans-
aminases after Lachesis muta envenomation in humans.
Hematological parameters
Our results showed a significant initial increase (1 h) of
hematocrit values followed by decay (24 h), in the
groups injected with venom (Fig. 2 – a), with and with-
out treatment (LmrV, LmrV + AmL and LmrV + AmJ).
These values drop significantly after 24 h. The same effect,
an initial increase and decrease after 24 h, was also ob-
served in total hemoglobin concentrations (Fig. 2 – b), as
well as in the red blood cell count (Fig. 2 – c), being the
increase significant only in the group LmrV +AmL (1 h).
The treatments with AmL and AmJ appear to worsen the
hematological profile induced by LmrV, since the treated
groups showed a significant decrease of hemoglobin (24 h)
compared with LmrV group (Fig. 2 – b).
An evidence of envenomation by Lachesis muta rhom-
beata is indirect hemolytic effect induced by the PLA2
present in the venom, which acts on the phospholipids
of the cell membrane, causing the lysis of red blood cells
[25, 45]. Campos et al. [50] also attributed the hemolytic
effect to PLA2, since inhibition of this toxin by triazole
derivatives is capable of neutralizing the hemolytic activ-
ity of Lachesis muta venom. This effect probably occurs
due to the initial hemoconcentration caused by plasma
extravasations to tissues and dehydration due to diar-
rhea, probably due to the hemolytic action of the venom
toxins [25, 45, 51]. One hypothesis to justify this result with
the treated groups is the effect of soursop to treat diarrhea,
preventing the fluid loss by the animal [47]. In this sense,
for the same amount of hemoglobin, there is a greater vol-
ume of plasma, leading to decreases in the total
hemoglobin concentration. The same pattern is observed in
the red blood cell count and hematocrit (Fig. 2 – a and c).
Several case reports show hematological changes dur-
ing the envenomation. Pardal et al. [8] reported these
changes during 24 h after envenomation by Lachesis. On
admission at the hospital, the hematocrit of the patient
was 40 % and the total hemoglobin 11.3 g/L. After 24 h,
the hematocrit was under 25 % and hemoglobin 8.1 g/L.
A similar profile was described by Jorge et al. [7], in
which they report hematocrit values of 54 % two hours
after the snake bite, and 47 % after 24 h. The same oc-
curred with the hemoglobin concentration, which was
18.2 g/dL after two hours and 16 g/dL after 24 h of en-
venomation. The decrease of hemoglobin concentration
was accompanied by reduction of total red blood cells.
Hemostatic parameters
We found a significant increase in prothrombin time
(Fig. 3 – a) and an increase of partial thromboplastin
time (Fig. 3 – b) in the first hour after the venom injec-
tion (LmrV 1 h). A tendency to normalization was ob-
served in the following hours (6 and 24 h). Groups
treated with AmL and AmJ maintained prothrombin
time at values close to the control group, suggesting a
positive effect of the treatments with Annona muricata
L. on hemostasis. In the case reports published by Pardal
et al. [8] and Jorge et al. [7] there are descriptions of pa-
tients with incoagulable blood (clotting time test) even
26 h after the snakebite, and increased prothrombin time
and partial thromboplastin time values two hours after
the envenomation.
The envenomation by snakes of the Viperidae family
induces changes in hemostasis and causes hemorrhagic
syndromes. These processes involve a large number of
molecules that promote microvascular damage or interfere
with the coagulation cascade, and as pro- and antiaggregat-
ing toxins affecting blood platelets. Metalloproteinases,
thrombin-like serine proteinases, PLA2 and type-C lectins
are involved in this process [10, 17, 23, 27, 52–55]. To-
gether they cause an imbalance in the hemostatic system
and tissues repair, leading to persistent bleeding.
Blood pressure
The evaluation of blood pressure during Lachesis en-
venomation is very important, since the snakebite causes
an intense decrease in blood pressure, commonly seen
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in envenomation in humans [45]. The hypotension is
provoked by the combined autonomic and hemorrhagic
effects as well as bradycardia. The vagal symptomatology
consists of the following symptoms: sweating, nausea,
vomiting, abdominal cramps, diarrhea, hypotension and
bradycardia and is probably caused by PLA2 [29, 56].
The hemorrhagic effects are due to the actions of
thrombin-like serine proteinases and metalloproteinases,
which deplete the reserves of fibrinogen and cause
microvascular damage, respectively.
A time-dependent tendency of blood pressure reduc-
tion was observed in the animals injected with LmrV, es-
pecially after 24 h, in all groups analyzed (Fig. 4). It is
important to note that the reduction of blood pressure
was more pronounced in animals injected with LmrV
and treated with AmL or AmJ than in animals only
injected with LmrV, especially 1 and 6 h after envenom-
ation. Although the treatment with the juice (LmrV +
AmJ) has not presented significant differences when
compared to the untreated group (LmrV), the results
indicate that AmJ may potentiate the hypotensive
effect of LmrV. We also noted a slight hypotensive
effect in the control group of Annona muricata L.
juice (C + AmJ).
Studies in animal models demonstrated hypotensive,
vasodilator and cardiac depressant effects of Annona
muricata L. and its use is not recommended for
people with hypotension [47]. Due to this natural ef-
fect of the plant, the treatment with soursop juice
could intensify the hypotension observed in human
Fig. 2 a Hematocrit, b total hemoglobin concentration, c total red blood cells count in whole blood of male Wistar rats injected with 3 mg of
Lachesis muta rhombeata venom, at 1, 6 and 24 h after envenomation (LmrV) and with their respective treatments with aqueous extract of
Annona muricata L. leaves (LmrV + AmL) or Annona muricata L. juice (LmrV + AmJ). The numbers above the columns represent the number of
animals used in each test. *** p < 0.001, ** p < 0.01 compared to control group. °°° p < 0.001 compared to the envenomation group (LmV)
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envenomation, as shown in case reports of snakebites
caused by Lachesis genus [9, 45].
A. muricata L. reduces blood pressure by a mechan-
ism that does not involve muscarinic, endothelial, hista-
minergic, adrenergic or endothelial-dependent pathways.
The more likely mechanism of action is Ca2+ antagon-
ism, involving voltage dependent Ca2+ channel blockade
and/or inhibition of Ca2+ release from intracellular
stores of the blood vessels [57]. The hypotensive effect
of A. muricata may be attributed to the combined action
of alkaloids and essential oils present in the plant. The
alkaloids, isoquinoline, coreximine and anomurine exert
a transient depressive effect on the blood pressure. The
essential oil beta-caryophyllene exhibits hypotensive and
Fig. 3 a Determination of prothrombin time and b partial thromboplastin time in plasma of male Wistar rats injected with 3 mg of Lachesis muta
rhombeata venom, at 1, 6 and 24 h after envenomation (LmrV) and with their respective treatments with aqueous extract of Annona muricata L.
leaves (LmrV + AmL) or Annona muricata L. juice (LmrV + AmJ). The numbers above the columns represent the number of animals used in each
test. *** p < 0.001, ** p < 0.01 compared to control group. °° p < 0.001 compared to the envenomation group (LmrV)
Fig. 4 Variation of systolic blood pressure during 24 h after the envenomation with Lachesis muta rhombeata venom (LmrV) and their respective
treatments with aqueous extract of Annona muricata L. leaves (LmrV + AmL) or Annona muricata L. juice (LmrV + AmJ). The animals, male Wistar
rats, were injected with 3 mg of Lachesis muta rhombeata venom and the blood pressure was measured before the venom injection and at 1, 6
and 24 h after the envenomation. The numbers above the columns represent the number of animals used in each test
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vasodilator effects. Furthermore, reticuline, another alkaloid
found in Annona muricata leaves, can cause hypotension
through voltage-dependent Ca2+ channel blockade and/or
inhibition of Ca2+ release from norepinephrine-sensitive
intracellular stores [57].
Inflammatory process
Serum proteins
Most of serum proteins are involved in the inflammatory
response, as positive acute-phase proteins or negative
acute-phase proteins [42]. Our analysis (Table 1) shows
the serum protein profile of animals at different times
(1, 6 and 24 h) after envenomation (LmrV) and treated
with AmL or AmJ, showing alterations related to the in-
flammatory response induced by LmrV. The albumin
significantly decreases 6 and 24 h after LmrV injection,
with and without the treatments (AmL and AmJ), a re-
sult that is confirmed by the biochemical analysis of this
protein (Fig. 1 – b).
The alpha-1 zone is composed of positive acute-phase
proteins such as proteinase inhibitors, and is increased
24 h after the envenomation without treatment (LmrV
24 h), due to the acute inflammatory process triggered
by the venom. The same occurs with the alpha-2 zone,
which is also composed of positive acute-phase proteins,
and is increased in untreated groups (LmrV 24 h) and in
the group treated with aqueous extract of Annona muri-
cata L. leaves (LmrV + AmL 24 h).
The beta zone is mainly represented by transferrin and
C3 component of complement system, and can be di-
vided into beta-1 and beta-2 zones. There is a significant
increase in beta zone in the groups injected with venom
Table 1 Percentages of serum proteins of the animals at different times after envenomation
Groups Na Albumin (%)b Alfa-1 (%)b Alfa-2 (%)b Beta-1 (%)b Beta-2 (%)b Gama (%)b
Control 36 59.84 ± 0.51 15.10 ± 0.72 8.61 ± 0.31 5.76 ± 0.19 8.39 ± 0.18 2.02 ± 0.08
C + AmL 27 59.46 ± 0.67 14.88 ± 0.63 9.67 ± 0.62 5.84 ± 0.19 8.28 ± 0.17 1.92 ± 0.10
C + AmJ 28 59.66 ± 0.66 15.61 ± 0.86 6.60 ± 0.62 6.20 ± 0.23 8.88 ± 0.18 2.32 ± 0.13
LmrV 1h 10 56.14 ± 1.24 18.72 ± 1.17 8.15 ± 0.72 5.69 ± 0.20 8.76 ± 0.31 2.54 ± 0.27
LmrV 6h 10 55.56 ± 0.81* 18.20 ± 0.75 9.47 ± 0.74 6.52 ± 0.43 8.03 ± 0.26 2.21 ± 0.24
LmrV 24h 9 45.60 ± 0.92* 21.22 ± 0.78* 14.82 ± 1.90* 12.33 ± 0.28* 8.80 ± 0.24 1.70 ± 0.27
LmrV + AmL 1h 5 56.50 ± 0.54 20.44 ± 0.45 6.34 ± 0.26 5.76 ± 0.22 9.12 ± 0.22 1.62 ± 0.20
LmrV + AmL 6h 6 54.20 ± 0.41* 19.30 ± 0.52 7.68 ± 0.60 7.25 ± 0.20 9.50 ± 0.36 1.70 ± 0.27
LmrV + AmL 24h 5 40.70 ± 1.81* 17.10 ± 1.36 12.82 ± 0.44* 10.42 ± 0.30* 15.28 ± 2.56*° 2.12 ± 0.24
LmrV + AmJ 1h 6 57.43 ± 0.73 16.55 ± 0.34 9.82 ± 0.58 5.53 ± 0.33 8.50 ± 0.34 2.16 ± 0.14
LmrV + AmJ 6h 6 52.78 ± 1.48* 20.02 ± 0.66 7.28 ± 0.49 6.98 ± 0.68 9.97 ± 0.26 2.66 ± 0.42
LmrV + AmJ 24h 6 40.33 ± 1.81* 19.35 ± 1.01 10.95 ± 0.99 10.87 ± 0.44* 14.70 ± 2.22*° 2.05 ± 0.24
Male Wistar rats were injected with 3 mg of Lachesis muta rhombeata venom, at 1, 6 and 24 h after envenomation (LmrV) and treated respectively with aqueous
extract of Annona muricata L. leaves (LmrV + AmL) or Annona muricata L. juice (LmrV + AmJ)
aNumber of animals per group. bPercentages of serum proteins estimated by densitometry, represented by mean ± SEM. * p < 0.05, significant difference
compared to control group. ° p < 0.05, significant difference compared to envenomation LmrV group (without treatment)
Fig. 5 Interleukin-6 concentration of male Wistar rats injected with 3 mg of Lachesis muta rhombeata venom, at 1, 6 and 24 h after
envenomation (LmrV) and with their respective treatment with aqueous extract of Annona muricata L. leaves (LmrV + AmL) or Annona muricata L.
juice (LmrV + AmJ). The numbers above the columns represent the number of animals used in each test. *** p < 0.001, ** p < 0.01, * p < 0.05
compared to control group
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after 24 h, with and without treatment (LmrV 24 h,
LmrV + AmL 24 h and LmrV + AmJ 24 h). The gama
zone, composed by imunoglobulins, did not show any
changes during the envenomation. These results confirm
the inflammatory process triggered by the venom. Add-
itionally, they show that treatments did not interfere
with these parameters.
Interleukin-6
We observed increased concentrations of IL-6 mainly 6
h after envenomation (Fig. 5). Treatment did not inter-
fere with this LmrV effect. The IL-6 increase is consist-
ent with other results already obtained, initiating and
propagating the acute phase inflammatory response to
the injury induced by the envenomation.
IL-6 has both pro-inflammatory and anti-inflammatory
properties. It is often used as a marker to evaluate the
inflammatory process and has been correlated with the
severity of envenomation, together with other pro-
inflammatory cytokines, such as TNF-alpha, IL-1b, IL-8,
IL-10, IL-12 and COX-2 [58–63]. IL-6 cannot be uniquely
related to pro-inflammatory response. It is known
that the soluble form of IL-6 receptor is related to its
pro-inflammatory activity whereas classic IL-6 is re-
quired for regenerative or anti-inflammatory activities
of the cytokine [64, 65].
Fig. 6 a Total white blood cells count, b relative count of lymphocytes and c segmented neutrophils of male Wistar rats injected with 3 mg of
Lachesis muta rhombeata venom, at 1, 6 and 24 h after envenomation (LmrV) and with their respective treatments with aqueous extract of
Annona muricata L. leaves (LmrV + AmL) or Annona muricata L. juice (LmrV + AmJ). The numbers above the columns represent the number of
animals used in each test. *** p < 0.001, ** p < 0.01 compared to control group. °° p < 0.001, ° p < 0.001 compared to envenomation group
without treatment (LmV)
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Total and relative white blood cells count
The venom itself was not sufficient to alter significantly
the total white blood cell count (Fig. 6 – a). However,
there was a time-dependent trend in the increasing
number of leukocytes in animals injected with venom
without treatment (LmrV).
The differential leukocyte count of the groups injected
with Lachesis muta rhombeata venom clearly shows the
reduction of lymphocytes in the early hours after en-
venomation over the increasing of neutrophil number
(Fig. 6 – b and c, respectively), and an increase of lym-
phocytes 24 h after envenomation accompanied by a de-
crease in the number of neutrophils. This effect of the
venom on defense cells can be explained by the clonal
expansion of B lymphocytes during the production of
antibodies specific for the toxins present in the venom
[66]. Neutrophilia occurs in the early hours of envenom-
ation and returns to normal within 24 h after envenom-
ation, indicating the recruitment of these cells to sites
where tissue damages were intense.
Lethality assay
The determination of the lethal dose 50 % (LD50) is es-
sential for the standardization of antivenoms of natural
origin, which justifies this test in order to evaluate the
efficiency of treatment with AmL and AmJ for cases of
Lachesis muta rhombeata envenomation.
The LD50 obtained in this study in the untreated group
(LmrV) was 51.0 ± 6.4 mg/kg (44.6 to 57.4 mg/kg). The
LD50 obtained for the group injected with the venom and
treated with soursop juice (LmrV +AmJ) was 56.3 ± 8.5
mg/kg (47.8 to 64.8 mg/kg) and the LD50 obtained for the
group injected with the venom and treated with aqueous
extract of soursop leaves (LmrV +AmL) was 62.2 ± 6.8
mg/kg (55.4 to 69.0 mg/kg). These results show that the
treatment did not significantly alter the LD50 values of the
venom, when considering the fiducial limits for each test.
Conclusion
The clinical profile of the envenomation caused by La-
chesis muta rhombeata was well documented and very
detailed for the first 24 h after the injection of the
venom, and could evaluate the efficiency of the popular
use of soursop (Annona muricata L.) as natural anti-
venom in snakebites caused by this specie.
In general, the treatments with AmL and AmJ do not
alter relevantly the lethality of the envenomation, as the
LD50 values have shown. They played a role in the main-
tenance of blood glucose and the coagulation parameters
and exert a protective action against the myotoxicity of
the venom. However, both treatments seem to worsen
the hypotensive effect induced by LmrV. Therefore, add-
itional studies with A. muricata are necessary to deter-
mine its suitable forms of use and mechanism of action
in order to enable its safe and effective use as natural
antivenom for bushmaster snakebite.
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